Acantholytic dyskeratotic epidermal nevus
Acantholytic dyskeratotic epidermal nevus is a rare type of epidermal nevus characterized by specific histological features, including acantholysis and dyskeratosis. This condition is typically present at birth or develops in early childhood and manifests as localized or widespread skin lesions.
Presentation[edit | edit source]
The lesions of acantholytic dyskeratotic epidermal nevus often appear as hyperkeratotic plaques or papules that may be skin-colored, brown, or reddish. These lesions can be linear or follow the lines of Blaschko's lines, which are patterns of skin cell development. The affected areas may be asymptomatic or associated with mild pruritus.
Histopathology[edit | edit source]
Histologically, acantholytic dyskeratotic epidermal nevus is characterized by:
- Acantholysis: Loss of cohesion between keratinocytes.
- Dyskeratosis: Abnormal keratinization of individual keratinocytes.
- Hyperkeratosis: Thickening of the stratum corneum.
- Parakeratosis: Retention of nuclei in the stratum corneum.
These features distinguish it from other types of epidermal nevi and other skin conditions.
Diagnosis[edit | edit source]
The diagnosis of acantholytic dyskeratotic epidermal nevus is primarily based on clinical examination and confirmed by skin biopsy and histopathological analysis. Differential diagnosis includes other types of epidermal nevi, Darier's disease, and Hailey-Hailey disease.
Treatment[edit | edit source]
There is no definitive cure for acantholytic dyskeratotic epidermal nevus. Treatment options are aimed at managing symptoms and may include:
- Topical keratolytics to reduce hyperkeratosis.
- Topical retinoids to promote normal keratinization.
- Laser therapy for cosmetic improvement.
Prognosis[edit | edit source]
The prognosis for individuals with acantholytic dyskeratotic epidermal nevus is generally good, as the condition is benign. However, the lesions may persist throughout life and can cause cosmetic concerns.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD